Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Splenic flexure mobilization for sigmoid and low anterior resections in the minimally invasive era: How often and at what cost?

Pettke E, Leigh N, Shah A, Cekic V, Yan X, Kumara HMCS, Gandhi N, Whelan RL.

Am J Surg. 2019 Sep 26. pii: S0002-9610(19)30101-1. doi: 10.1016/j.amjsurg.2019.09.029. [Epub ahead of print]

PMID:
31582178
2.

Plasma and wound fluid levels of eight proangiogenic proteins are elevated after colorectal resection.

Shantha Kumara H, Yan XH, Pettke E, Cekic V, Gandhi ND, Bellini GA, Whelan RL.

World J Gastrointest Oncol. 2019 Jun 15;11(6):470-488. doi: 10.4251/wjgo.v11.i6.470.

3.

Opioid prescription and postoperative outcomes in pediatric patients.

Whelan RL, McCoy J, Mirson L, Chi DH.

Laryngoscope. 2019 Jun;129(6):1477-1481. doi: 10.1002/lary.27614. Epub 2018 Dec 26.

PMID:
30585626
4.

Plasma levels of the proangiogenic protein CXCL16 remains elevated for 1 month after minimally invasive colorectal cancer resection.

Shantha Kumara HMC, Pettke E, Shah A, Yan X, Cekic V, Downing MA, Gandhi ND, Whelan RL.

World J Surg Oncol. 2018 Jul 7;16(1):132. doi: 10.1186/s12957-018-1418-2.

5.

Plasma interleukin-8 levels are persistently elevated for 1 month after minimally invasive colorectal resection for colorectal cancer.

Shantha Kumara HMC, Sutton E, Bellini GA, Yan X, Cekic V, Gandhi ND, Whelan RL.

Mol Clin Oncol. 2018 Mar;8(3):471-476. doi: 10.3892/mco.2017.1538. Epub 2017 Dec 18.

6.

Reducing rates of operative intervention for pediatric post-tonsillectomy hemorrhage.

Whelan RL, Shaffer A, Anderson ME, Hsu J, Jabbour N.

Laryngoscope. 2018 Aug;128(8):1958-1962. doi: 10.1002/lary.27076. Epub 2018 Jan 4.

PMID:
29314032
7.

P-Cadherin (CDH3) is overexpressed in colorectal tumors and has potential as a serum marker for colorectal cancer monitoring.

Kumara HMCS, Bellini GA, Caballero OL, Herath SAC, Su T, Ahmed A, Njoh L, Cekic V, Whelan RL.

Oncoscience. 2017 Oct 21;4(9-10):139-147. doi: 10.18632/oncoscience.370. eCollection 2017 Sep.

8.

Warm and Humidified Versus Cold and Dry CO2 Pneumoperitoneum in Minimally Invasive Colon Resection: A Randomized Controlled Trial.

Sutton E, Bellini G, Grieco MJ, Kumara HMCS, Yan X, Cekic V, Njoh L, Whelan RL.

Surg Innov. 2017 Oct;24(5):471-482. doi: 10.1177/1553350617715834. Epub 2017 Jun 27.

PMID:
28653583
9.

Robert Madoff, the Man.

Whelan RL.

Dis Colon Rectum. 2017 Jun;60(6):560-564. doi: 10.1097/DCR.0000000000000808. No abstract available.

PMID:
28481848
10.

Risk factors for superficial surgical site infection after elective rectal cancer resection: a multivariate analysis of 8880 patients from the American College of Surgeons National Surgical Quality Improvement Program database.

Sutton E, Miyagaki H, Bellini G, Shantha Kumara HM, Yan X, Howe B, Feigel A, Whelan RL.

J Surg Res. 2017 Jan;207:205-214. doi: 10.1016/j.jss.2016.08.082. Epub 2016 Aug 31.

PMID:
27979478
11.

Plasma chitinase 3-like 1 is persistently elevated during first month after minimally invasive colorectal cancer resection.

Shantha Kumara HM, Gaita D, Miyagaki H, Yan X, Hearth SA, Njoh L, Cekic V, Whelan RL.

World J Gastrointest Oncol. 2016 Aug 15;8(8):607-14. doi: 10.4251/wjgo.v8.i8.607.

12.

Human Blood Autoantibodies in the Detection of Colorectal Cancer.

Negm OH, Hamed MR, Schoen RE, Whelan RL, Steele RJ, Scholefield J, Dilnot EM, Shantha Kumara HM, Robertson JF, Sewell HF.

PLoS One. 2016 Jul 6;11(7):e0156971. doi: 10.1371/journal.pone.0156971. eCollection 2016.

13.

Surgical Treatment of Diverticulitis: Hand-Assisted Laparoscopic Resection Is Predominantly Used for Complex Cases and Is Associated With Increased Postoperative Complications and Prolonged Hospitalization.

Miyagaki H, Rhee R, Shantha Kumara HM, Yan X, Njoh L, Cekic V, Whelan RL.

Surg Innov. 2016 Jun;23(3):277-83. doi: 10.1177/1553350615618285. Epub 2015 Nov 26.

PMID:
26611789
14.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M.

Semin Cancer Biol. 2015 Dec;35 Suppl:S276-S304. doi: 10.1016/j.semcancer.2015.09.007. Review.

15.

Expression of the cancer testis antigen IGF2BP3 in colorectal cancers; IGF2BP3 holds promise as a specific immunotherapy target.

Shantha Kumara H, Kirchoff D, Caballero OL, Su T, Ahmed A, Herath SA, Njoh L, Cekic V, Simpson AJ, Cordon-Cardo C, Whelan RL.

Oncoscience. 2015 Jul 1;2(6):607-14. eCollection 2015.

16.

A multi-targeted approach to suppress tumor-promoting inflammation.

Samadi AK, Bilsland A, Georgakilas AG, Amedei A, Amin A, Bishayee A, Azmi AS, Lokeshwar BL, Grue B, Panis C, Boosani CS, Poudyal D, Stafforini DM, Bhakta D, Niccolai E, Guha G, Vasantha Rupasinghe HP, Fujii H, Honoki K, Mehta K, Aquilano K, Lowe L, Hofseth LJ, Ricciardiello L, Ciriolo MR, Singh N, Whelan RL, Chaturvedi R, Ashraf SS, Shantha Kumara HMC, Nowsheen S, Mohammed SI, Keith WN, Helferich WG, Yang X.

Semin Cancer Biol. 2015 Dec;35 Suppl:S151-S184. doi: 10.1016/j.semcancer.2015.03.006. Epub 2015 May 5. Review.

17.

Cancer prevention and therapy through the modulation of the tumor microenvironment.

Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, Crawford S, Fujii H, Georgakilas AG, Guha G, Halicka D, Helferich WG, Heneberg P, Honoki K, Keith WN, Kerkar SP, Mohammed SI, Niccolai E, Nowsheen S, Vasantha Rupasinghe HP, Samadi A, Singh N, Talib WH, Venkateswaran V, Whelan RL, Yang X, Felsher DW.

Semin Cancer Biol. 2015 Dec;35 Suppl:S199-S223. doi: 10.1016/j.semcancer.2015.02.007. Epub 2015 Apr 10. Review.

18.

Immune evasion in cancer: Mechanistic basis and therapeutic strategies.

Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara HMCS, Signori E, Honoki K, Georgakilas AG, Amin A, Helferich WG, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Choi BK, Kwon BS.

Semin Cancer Biol. 2015 Dec;35 Suppl:S185-S198. doi: 10.1016/j.semcancer.2015.03.004. Epub 2015 Mar 25. Review.

19.

Technique of last resort: characteristics of patients undergoing open surgery in the laparoscopic era.

Guend H, Lee DY, Myers EA, Gandhi ND, Cekic V, Whelan RL.

Surg Endosc. 2015 Sep;29(9):2763-9. doi: 10.1007/s00464-014-4007-7. Epub 2014 Dec 6.

PMID:
25480623
20.

Efficacy of laparoscopic-assisted approach for reversal of Hartmann's procedure: results from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database.

Arkenbosch J, Miyagaki H, Kumara HM, Yan X, Cekic V, Whelan RL.

Surg Endosc. 2015 Aug;29(8):2109-14. doi: 10.1007/s00464-014-3926-7. Epub 2014 Nov 1. Review.

PMID:
25361651
21.

Plasma monocyte chemotactic protein-1 remains elevated after minimally invasive colorectal cancer resection.

Shantha Kumara HM, Myers EA, Herath SA, Jang JH, Njoh L, Yan X, Kirchoff D, Cekic V, Luchtefeld M, Whelan RL.

World J Gastrointest Oncol. 2014 Oct 15;6(10):413-9. doi: 10.4251/wjgo.v6.i10.413.

22.

Surgical stapling device-tissue interactions: what surgeons need to know to improve patient outcomes.

Chekan E, Whelan RL.

Med Devices (Auckl). 2014 Sep 12;7:305-18. doi: 10.2147/MDER.S67338. eCollection 2014. Review.

23.

Minimally invasive colorectal resection is associated with significantly elevated levels of plasma matrix metalloproteinase 3 (MMP-3) during the first month after surgery which may promote the growth of residual metastases.

Shantha Kumara HM, Gaita DJ, Miyagaki H, Yan X, Herath SA, Cekic V, Whelan RL.

Surg Endosc. 2014 Dec;28(12):3322-8. doi: 10.1007/s00464-014-3612-9. Epub 2014 Jun 18.

PMID:
24939159
24.

Minimally invasive colorectal resection for benign pathology is associated with persistent proangiogenic plasma compositional changes.

Shantha Kumara HM, Myers EA, Herath SA, Njoh L, Yan X, Kirchoff D, Dujovny N, Whelan RL.

Dis Colon Rectum. 2014 Jun;57(6):740-6. doi: 10.1097/DCR.0000000000000062.

PMID:
24807599
25.

Endoscopic tattooing to mark distal margin for low anterior rectal and select sigmoid resections.

Kirchoff DD, Hang JH, Cekic V, Baxter K, Kumar P, Shehebar J, Holzman K, Whelan RL.

Surg Innov. 2014 Aug;21(4):376-80. doi: 10.1177/1553350613507147. Epub 2013 Oct 30.

PMID:
24172168
26.

Colorectal cancer in patients under 50 years of age: a retrospective analysis of two institutions' experience.

Myers EA, Feingold DL, Forde KA, Arnell T, Jang JH, Whelan RL.

World J Gastroenterol. 2013 Sep 14;19(34):5651-7. doi: 10.3748/wjg.v19.i34.5651.

27.

The rate for the use of hand-assisted laparoscopic methods is directly proportional to body mass index.

Myers EA, Feingold DL, Arnell TD, Njoh L, Cekic V, Jang JH, Naffouje S, Whelan RL.

Surg Endosc. 2014 Jan;28(1):108-15. doi: 10.1007/s00464-013-3135-9. Epub 2013 Aug 31.

PMID:
23996331
28.

Device-tissue interactions: a collaborative communications system.

Chekan E, Whelan RL, Feng AH.

Ann Surg Innov Res. 2013 Jul 29;7(1):10. doi: 10.1186/1750-1164-7-10.

29.

Predictors of mortality after emergency colectomy for Clostridium difficile colitis: an analysis of ACS-NSQIP.

Lee DY, Chung EL, Guend H, Whelan RL, Wedderburn RV, Rose KM.

Ann Surg. 2014 Jan;259(1):148-56. doi: 10.1097/SLA.0b013e31828a8eba.

PMID:
23470584
30.

MAGE-A3 is highly expressed in a subset of colorectal cancer patients.

Shantha Kumara HM, Grieco MJ, Caballero OL, Su T, Ahmed A, Ritter E, Gnjatic S, Cekic V, Old LJ, Simpson AJ, Cordon-Cardo C, Whelan RL.

Cancer Immun. 2012;12:16. Epub 2012 Dec 28.

31.

Laparoscopic-facilitated endoscopic submucosal dissection, mucosal resection, and partial circumferential ("wedge") colon wall resection for benign colorectal neoplasms that come to surgery.

Jang JH, Kirchoff D, Holzman K, Park K, Grieco M, Cekic V, Naffouje S, Kluft J, Whelan RL.

Surg Innov. 2013 Jun;20(3):234-40. doi: 10.1177/1553350612456098. Epub 2012 Aug 1.

PMID:
22858573
32.
33.

Perioperative polyphenon E, a green tea extract, does not affect the wound complication rate in mice after sham laparotomy yet has an inhibitory effect on wound healing.

Hoffman A, Baxter R, Nasar A, Gardner TR, Kumara S, Cordon-Cardo C, Ahmed A, Newman RA, Zmora O, Whelan RL.

Surg Innov. 2012 Dec;19(4):399-406. doi: 10.1177/1553350612436565. Epub 2012 Mar 18.

PMID:
22431911
34.

Perioperative polyphenon E- and siliphos-inhibited colorectal tumor growth and metastases without impairment of gastric or abdominal wound healing in mouse models.

Yan X, Gardner TR, Grieco M, Herath SA, Jang JH, Kirchoff D, Njoh L, Shantha Kumara HM, Naffouje S, Whelan RL.

Surg Endosc. 2012 Jul;26(7):1856-64. doi: 10.1007/s00464-011-2114-2. Epub 2012 Jan 19.

PMID:
22258296
35.

Plasma soluble vascular adhesion molecule-1 levels are persistently elevated during the first month after colorectal cancer resection.

Shantha Kumara HM, Tohme ST, Herath SA, Yan X, Senagore AJ, Nasar A, Kalady MF, Baxter R, Whelan RL.

Surg Endosc. 2012 Jun;26(6):1759-64. doi: 10.1007/s00464-011-2112-4. Epub 2012 Jan 5.

PMID:
22219007
36.

Plasma from the second and third weeks after open colorectal resection for cancer stimulates in vitro endothelial cell growth, migration, and invasion.

Shantha Kumara HM, Kirchoff D, Naffouje S, Grieco M, Herath SA, Dujovny N, Kalady MF, Hyman N, Njoh L, Whelan RL.

Surg Endosc. 2012 Mar;26(3):790-5. doi: 10.1007/s00464-011-1953-1. Epub 2011 Nov 15.

PMID:
22083320
37.

Oncologic colorectal resection, not advanced endoscopic polypectomy, is the best treatment for large dysplastic adenomas.

Jang JH, Balik E, Kirchoff D, Tromp W, Kumar A, Grieco M, Feingold DL, Cekic V, Njoh L, Whelan RL.

J Gastrointest Surg. 2012 Jan;16(1):165-71; discussion 171-2. doi: 10.1007/s11605-011-1746-9. Epub 2011 Nov 5.

PMID:
22058042
38.

Laparoscopic-facilitated colonic endoscopic mucosal resection and endoscopic submucosal resection of adenomas: techniques to avoid segmental colectomy.

Whelan RL.

J Gastrointest Surg. 2011 Aug;15(8):1309-12. doi: 10.1007/s11605-011-1574-y. Epub 2011 Jun 29. No abstract available.

PMID:
21713587
39.

Minimally invasive colorectal resection is associated with a transient increase in plasma hepatocyte growth factor levels early after surgery for colon cancer.

Shantha Kumara HM, Tohme ST, Kim IY, Kim DG, Kalady MF, Luchtefeld M, Hoffman K, Dimaggio V, Whelan RL.

Surg Innov. 2011 Sep;18(3):254-8. doi: 10.1177/1553350611399588. Epub 2011 Mar 11.

PMID:
21398340
40.

CpG ODN, Toll like receptor (TLR)-9 agonist, inhibits metastatic colon adenocarcinoma in a murine hepatic tumor model.

Kim IY, Yan X, Tohme S, Ahmed A, Cordon-Cardo C, Shantha Kumara HM, Kim SK, Whelan RL.

J Surg Res. 2012 May 15;174(2):284-90. doi: 10.1016/j.jss.2010.12.021. Epub 2011 Jan 15.

PMID:
21324492
41.

Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection.

Shantha Kumara HM, Cabot JC, Yan X, Herath SA, Luchtefeld M, Kalady MF, Feingold DL, Baxter R, Whelan RL.

Surg Endosc. 2011 Jul;25(7):2153-8. doi: 10.1007/s00464-010-1514-z. Epub 2010 Dec 24.

PMID:
21184108
42.

Plasma levels of angiostatin and endostatin remain unchanged for the first 3 weeks after colorectal cancer surgery.

Shantha Kumara HM, Tohme ST, Yan X, Nasar A, Senagore AJ, Kalady MF, Hyman N, Kim IY, Whelan RL.

Surg Endosc. 2011 Jun;25(6):1939-44. doi: 10.1007/s00464-010-1491-2. Epub 2010 Dec 22.

PMID:
21181203
43.

Is there a role for a strict incision length criterion for determining conversions during laparoscopic colorectal resection?

Offodile AC 2nd, Balik E, Hoffman A, Moon V, Baxter R, Grieco M, Moradi D, Kim IY, Nasar A, Cekic V, Feingold DL, Arnell TD, Huang E, Whelan RL.

Surg Innov. 2010 Jun;17(2):120-6. doi: 10.1177/1553350610366715.

PMID:
20504788
44.

Minimally invasive colorectal resection for cancer is associated with a short-lived decrease in soluble Tie-2 receptor levels, which may transiently inhibit VEGF-mediated angiogenesis (via altered blood levels of free Ang-1 and Ang-2).

Shantha Kumara HM, Grieco MJ, Yan X, Kalady MF, DiMaggio V, Kim DG, Hyman N, Feingold DL, Whelan RL.

Surg Endosc. 2010 Oct;24(10):2581-7. doi: 10.1007/s00464-010-1008-z. Epub 2010 Mar 31.

PMID:
20354881
45.

Minimally invasive colorectal resection is associated with a rapid and sustained decrease in plasma levels of epidermal growth factor (EGF) in the colon cancer setting.

Grieco MJ, Shantha Kumara HM, Baxter R, Dujovny N, Kalady MF, Cekic V, Luchtefeld M, Whelan RL.

Surg Endosc. 2010 Oct;24(10):2617-22. doi: 10.1007/s00464-010-1018-x. Epub 2010 Mar 31.

PMID:
20354877
46.

High incidence of technical errors involving the EEA circular stapler: a single institution experience.

Offodile AC 2nd, Feingold DL, Nasar A, Whelan RL, Arnell TD.

J Am Coll Surg. 2010 Mar;210(3):331-5. doi: 10.1016/j.jamcollsurg.2009.11.007. Epub 2010 Feb 8.

PMID:
20193897
47.

Long-term consequences of not closing the mesenteric defect after laparoscopic right colectomy.

Cabot JC, Lee SA, Yoo J, Nasar A, Whelan RL, Feingold DL.

Dis Colon Rectum. 2010 Mar;53(3):289-92. doi: 10.1007/DCR.0b013e3181c75f48.

PMID:
20173475
48.

Increased utilization of flexible endoscopic methods during colorectal resection over a 3-year period.

DiMaggio V, Hoffman K, Baxter R, Cekic V, Nasar A, Whelan RL.

Surg Innov. 2009 Dec;16(4):293-8. doi: 10.1177/1553350609355806. Epub 2009 Dec 22.

PMID:
20031946
49.

Platelet-derived growth factor (subtype BB) is elevated in patients with colorectal carcinoma.

Belizon A, Balik E, Horst PK, Shantha Kumara HM, Nasar A, Whelan RL.

Dis Colon Rectum. 2009 Jun;52(6):1166-71. doi: 10.1007/DCR.0b013e3181a0b388.

PMID:
19581863
50.

Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery.

Shantha Kumara HM, Cabot JC, Hoffman A, Luchtefeld M, Kalady MF, Hyman N, Feingold D, Baxter R, Whelan RL.

Surg Endosc. 2010 Feb;24(2):283-9. doi: 10.1007/s00464-009-0575-3. Epub 2009 Jun 24.

PMID:
19551437

Supplemental Content

Loading ...
Support Center